<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117853">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02149069</url>
  </required_header>
  <id_info>
    <org_study_id>BMP - TRASFU1</org_study_id>
    <nct_id>NCT02149069</nct_id>
  </id_info>
  <brief_title>Blood Management Program in the Post - Operative Period.</brief_title>
  <official_title>Blood Management Program: Appropriateness of Transfusion Therapy in the Post - Operative Period.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arcispedale Santa Maria Nuova-IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arcispedale Santa Maria Nuova-IRCCS</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A care path in the field of transfusion medicine was creates at ASMN - IRCCS addressed  to
      patients undergoing complex surgical procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pathway is called Blood Management Program (BMP).

      The implementation of this process should improve transfusion therapy in the peri-operative
      period in order to:

        -  correct the transfusional approach to surgical patients

        -  optimize the management of transfusional resources (red blood cells, plasma, platelets)

        -  optimize the management of plasma derivatives, drugs and techniques designed to limit
           the use of homologous blood
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Evaluation of therapeutic appropriateness for Red Cells - Plasma - Platelets transfusion: comparison between prospective vs. retrospective data in ASMN ,Reggio Emilia (Italy)</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Excessive Amount of Blood / Fluid Transfusion</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing complex surgical procedures
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -All patients undergoing complex surgical procedures

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erminia Di Bartolomeo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ASMN-IRCCS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Berni Pamela, Doctor</last_name>
    <phone>0039-0522-295601</phone>
    <email>pamela.berni@asmn.re.it</email>
  </overall_contact>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 28, 2014</lastchanged_date>
  <firstreceived_date>May 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Arcispedale Santa Maria Nuova-IRCCS</investigator_affiliation>
    <investigator_full_name>PAMELABERNI</investigator_full_name>
    <investigator_title>Data Manager</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
